pillbase.ru

Beovu

Active substance: Brolucizumab

brolucizumab

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Визкью®
    раствор для внутриглазного введения, 120 мг/мл, 0.23 мл (original in Russian, GRLS)
    ЛП-№(009532)-(РГ-RU)
    Новартис Оверсиз Инвестментс АГ
  • Визкью®
    раствор для внутриглазного введения, 120 мг/мл, 0.23 мл (original in Russian, GRLS)
    ЛП-006598
    Новартис Оверсиз Инвестментс АГ
US 1
  • BEOVU
    INJECTION, SOLUTION · BROLUCIZUMAB 6 mg/.05mL
    0078-0827
    Novartis Pharmaceuticals Corporation
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-a66e-786d-b566-22e288691ae4,01a120c5-e50b-7bf3-bf10-39fe372e8a9a;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4882-791a-be3d-c1bdef88015b;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004913
Registration status
Active
ATC code
S01
Sources
  • product · EMA · EMEA/H/C/004913 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004913 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004913 · Verified 2026-10-09